Malden, Deborah E.
McLaughlin, John M.
Hong, Vennis
Lewnard, Joseph
Ackerson, Bradley K.
Puzniak, Laura
Kim, Jeniffer S.
Takhar, Harpreet
Frankland, Timothy B.
Slezak, Jeff M.
Tartof, Sara Y.
Funding for this research was provided by:
Pfizer
Article History
Received: 27 July 2023
Accepted: 20 March 2024
First Online: 29 March 2024
Competing interests
: JAL has received grants and consultancy fees from Pfizer. SYT and TF have received grants from Pfizer paid directly to their institution. LP and JMM are employees of Pfizer and hold stock and stock options in Pfizer. BKA receives research support from Dynavax, Moderna, GlaxoSmithKline, Pfizer and Genentech, for projects outside of the submitted work. JS has received grants from Pfizer, ALK Inc., Novavax and Dynavax Technologies paid directly to his institution. DM, VH and JK have no conflicts of interest to declare. This study was funded by Pfizer.